#BEGIN_DRUGCARD DB02596

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H18N5O12P3

# Chemical_IUPAC_Name:
({[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)methyl](hydroxy)phosphoryl}oxy)phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Antineoplastic Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Alpha,Beta-Methyleneadenosine-5'-Triphosphate

# HET_ID:
APC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H18N5O12P3/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(27-11)1-26-29(19,20)4-30(21,22)28-31(23,24)25/h2-3,5,7-8,11,17-18H,1,4H2,(H,19,20)(H,21,22)(H2,12,13,14)(H2,23,24,25)/t5-,7-,8+,11+/m0/s1

# InChI_Key:
InChIKey=CAWZRIXWFRFUQB-WOIOKPISSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2596

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
505.2082

# Molecular_Weight_Mono:
505.016480601

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1IH8

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.1

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
4.29e+00 g/l

# Primary_Accession_No:
DB02596

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6323221

# PubChem_Substance_ID:
46507991

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00539

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@@](O)(=O)C[P@](O)(=O)OP(O)(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:17 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L06495

# Drug_Target_1_GenBank_ID_Protein:
146013

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
folK

# Drug_Target_1_Gene_Sequence:
>480 bp
ATGACAGTGGCGTATATTGCCATAGGCAGCAATCTGGCCTCTCCGCTGGAGCAGGTCAAT
GCTGCCCTGAAAGCATTAGGCGATATCCCTGAAAGCCACATTCTTACCGTTTCTTCGTTT
TACCGCACCCCACCGCTGGGCCCGCAAGATCAACCCGATTACTTAAACGCAGCCGTGGCG
CTGGAAACCTCTCTTGCACCTGAAGAGCTACTCAATCACACACAGCGTATTGAATTGCAG
CAAGGTCGCGTCCGCAAAGCTGAACGCTGGGGACCACGCACGCTGGATCTCGACATCATG
CTGTTTGGTAATGAAGTGATAAATACTGAACGCCTGACCGTTCCGCACTACGATATGAAG
AATCGTGGATTTATGCTGTGGCCGCTGTTTGAAATCGCGCCGGAGTTGGTGTTTCCTGAT
GGGGAGATGTTGCGTCAAATCTTACATACAAGAGCATTTGACAAATTAAACAAATGGTAA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
10378268	Xiao B, Shi G, Chen X, Yan H, Ji X: Crystal structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase, a potential target for the development of novel antimicrobial agents. Structure. 1999 May;7(5):489-96.
10452528	Stammers DK, Achari A, Somers DO, Bryant PK, Rosemond J, Scott DL, Champness JN: 2.0 A X-ray structure of the ternary complex of 7,8-dihydro-6-hydroxymethylpterinpyrophosphokinase from Escherichia coli with ATP and a substrate analogue. FEBS Lett. 1999 Jul 30;456(1):49-53.
1325970	Talarico TL, Ray PH, Dev IK, Merrill BM, Dallas WS: Cloning, sequence analysis, and overexpression of Escherichia coli folK, the gene coding for 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase. J Bacteriol. 1992 Sep;174(18):5971-7.
1657875	Talarico TL, Dev IK, Dallas WS, Ferone R, Ray PH: Purification and partial characterization of 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase and 7,8-dihydropteroate synthase from Escherichia coli MC4100. J Bacteriol. 1991 Nov;173(21):7029-32.
2537812	Liu JD, Parkinson JS: Genetics and sequence analysis of the pcnB locus, an Escherichia coli gene involved in plasmid copy number control. J Bacteriol. 1989 Mar;171(3):1254-61.
8202364	Fujita N, Mori H, Yura T, Ishihama A: Systematic sequencing of the Escherichia coli genome: analysis of the 2.4-4.1 min (110,917-193,643 bp) region. Nucleic Acids Res. 1994 May 11;22(9):1637-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2644

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
18079

# Drug_Target_1_Name:
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase

# Drug_Target_1_Number_of_Residues:
159

# Drug_Target_1_PDB_ID:
1RB0

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01288	HPPK

# Drug_Target_1_Protein_Sequence:
>2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
MTVAYIAIGSNLASPLEQVNAALKALGDIPESHILTVSSFYRTPPLGPQDQPDYLNAAVA
LETSLAPEELLNHTQRIELQQGRVRKAERWGPRTLDLDIMLFGNEVINTERLTVPHYDMK
NRGFMLWPLFEIAPELVFPDGEMLRQILHTRAFDKLNKW

# Drug_Target_1_Reaction:
ATP + 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine = AMP + (2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl diphosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + 2-amino-4-hydroxy-6-hydroxymethyl-7,8- dihydropteridine = AMP + (2-amino-4-hydroxy-7,8-dihydropteridin-6- yl)methyl diphosphate

# Drug_Target_1_SwissProt_ID:
P26281

# Drug_Target_1_SwissProt_Name:
HPPK_ECOLI

# Drug_Target_1_Synonyms:
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase
7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase
EC 2.7.6.3
HPPK
PPPK

# Drug_Target_1_Theoretical_pI:
5.23

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
BX842583

# Drug_Target_2_GenBank_ID_Protein:
2113975

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
panC

# Drug_Target_2_Gene_Sequence:
>930 bp
TCAGTTTCTCCAATGTGATTCGAGGATTGCCCGGTATCCGTCCGGGCGGTCGGTGCCGGC
GAAAGTTCCGATTTCAATCGCAATGTTGTCCAGCAGCCTGGTGGTGCCAAGCCGGGCAGC
AACCAGCAGCCGACCGGAACCGTTGAGCGGCATCGGGCCAAGCCCGATATCGCGCAGCTC
CAGGTAGTCGACCGCCACGCCGGGTGCAGCGTCGAGCACCGCACGGGCGGCATCCAGCGC
GGCCTGCGCGCCAGCCGTTGCCGCATGCGCTGCGGCCGTTAGCGCCGCCGAGAGCGCGAC
GGCCGCCGCACGCTGGGCCGGGTCCAGGTAGCGGTTGCGCGACGACATCGCCAGCCCGTC
GGCTTCGCGCACGGTCGGCACGCCGACCACCGCGACATCGAGGTTGAAGTCCGCGACCAG
CTGCCGGATCAGCACCAGCTGCTGGTAGTCCTTCTCACCGAAGAACACCCGATCCGGGCG
CACGATCTGCAGCAGCTTTAGCACGACCGTCAGCACGCCGGCGAAATGGGTTGGCCGCGG
GCCGCCCTCGAGTTCGGCGGCCAACGGACCGGGTTGCACGGTGGTGCGCAGGCCGTCGGG
ATACATCGCCGCGGTAGTTGGCGTGAAAGCGATTTCCACGCCTTCGGCCCGCAGTTGCGC
CAGGTCGTCGTCCGGGGTGCGGGGATAGGCGTCGAGATCTTCCCCGGCACCGAATTGCAT
CGGGTTGACGAAGATCGACACGACGACGACCGATCCGGGCACCCGCTTGGCCGCACGCAC
CAACGCGAGGTGGCCTTCGTGCAGCGCACCCATAGTAGGCACCAACATCACTCGCCGGCC
GGTGAGTCGCAGTGCGCGACTGACATCGGCGACATCCCCCGGTGCCGAGTACACATTGAG
TTCACCGGGATGGAACGCAGGAATCGTCAT

# Drug_Target_2_General_Function:
Coenzyme transport and metabolism

# Drug_Target_2_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2532

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
32678

# Drug_Target_2_Name:
Pantoate--beta-alanine ligase

# Drug_Target_2_Number_of_Residues:
309

# Drug_Target_2_PDB_ID:
1N2O

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02569	Pantoate_ligase

# Drug_Target_2_Protein_Sequence:
>Pantoate--beta-alanine ligase
MTIPAFHPGELNVYSAPGDVADVSRALRLTGRRVMLVPTMGALHEGHLALVRAAKRVPGS
VVVVSIFVNPMQFGAGEDLDAYPRTPDDDLAQLRAEGVEIAFTPTTAAMYPDGLRTTVQP
GPLAAELEGGPRPTHFAGVLTVVLKLLQIVRPDRVFFGEKDYQQLVLIRQLVADFNLDVA
VVGVPTVREADGLAMSSRNRYLDPAQRAAAVALSAALTAAAHAATAGAQAALDAARAVLD
AAPGVAVDYLELRDIGLGPMPLNGSGRLLVAARLGTTRLLDNIAIEIGTFAGTDRPDGYR
AILESHWRN

# Drug_Target_2_Reaction:
ATP + (R)-pantoate + beta-alanine = AMP + diphosphate + (R)-pantothenate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + (R)-pantoate + beta-alanine = AMP + diphosphate + (R)-pantothenate

# Drug_Target_2_SwissProt_ID:
P0A5R0

# Drug_Target_2_SwissProt_Name:
PANC_MYCTU

# Drug_Target_2_Synonyms:
EC 6.3.2.1
Pantoate-activating enzyme
Pantothenate synthetase

# Drug_Target_2_Theoretical_pI:
5.96

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AF071051

# Drug_Target_3_GenBank_ID_Protein:
3420295

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
bls

# Drug_Target_3_Gene_Sequence:
>1542 bp
ATGGGGGCACCGGTTCTTCCGGCTGCCTTCGGGTTCCTGGCCTCCGCCCGAACGGGCGGG
GGCCGGGCCCCCGGCCCGGTCTTCGCGACCCGGGGCAGCCACACCGACATCGACACGCCC
CAGGGGGAGCGCTCGCTCGCGGCGACCCTGGTGCACGCCCCCTCGGTCGCGCCCGACCGC
GCGGTGGCGCGCTCCCTCACCGGCGCGCCCACCACCGCGGTGCTCGCCGGTGAGATCTAC
AACCGGGACGAACTCCTCTCCGTGCTGCCCGCCGGACCCGCGCCGGAGGGGGACGCGGAG
CTGGTCCTGCGGCTGCTGGAACGCTATGACCTGCATGCCTTCCGGCTGGTGAACGGGCGC
TTCGCGACCGTGGTGCGGACCGGGGACCGGGTCCTGCTCGCCACCGACCACGCCGGTTCG
GTGCCGCTGTACACCTGTGTGGCGCCGGGCGAGGTCCGGGCGTCCACCGAGGCCAAGGCG
CTCGCCGCGCACCGCGACCCGAAGGGCTTCCCGCTCGCGGACGCCCGCCGGGTCGCCGGT
CTGACCGGTGTCTACCAGGTGCCCGCGGGCGCCGTGATGGACATCGACCTCGGCTCGGGC
ACCGCCGTCACCCACCGCACCTGGACCCCGGGCCTCTCCCGCCGCATCCTGCCGGAGGGC
GAGGCCGTCGCGGCCGTGCGGGCCGCGCTGGAGAAGGCCGTCGCCCAGCGGGTCACCCCC
GGCGACACCCCGTTGGTGGTGCTCTCCGGCGGAATCGACTCCTCCGGGGTCGCGGCCTGT
GCGCACCGGGCGGCCGGGGAACTGGACACGGTGTCCATGGGCACCGACACGTCCAACGAG
TTCCGCGAGGCCCGGGCGGTCGTCGACCATCTGCGCACCCGGCACCGGGAGATCACCATC
CCGACCACCGAGCTGCTGGCGCAGCTCCCGTACGCGGTGTGGGCCTCCGAGTCGGTGGAC
CCGGACATCATCGAGTACCTGCTCCCCCTGACAGCGCTCTACCGGGCGCTCGACGGGCCG
GAGCGCCGCATCCTCACCGGGTACGGCGCGGACATCCCCCTCGGGGGCATGCACCGCGAG
GACCGGCTGCCCGCGCTGGACACCGTTCTCGCGCACGACATGGCCACCTTCGACGGGCTG
AACGAGATGTCCCCGGTGCTGTCCACGCTGGCGGGGCACTGGACCACCCACCCGTACTGG
GACCGGGAGGTCCTCGATCTGCTGGTCTCGCTGGAGGCCGGGCTCAAGCGGCGGCACGGC
CGGGACAAGTGGGTGCTGCGCGCCGCGATGGCCGACGCCCTCCCGGCGGAGACCGTCAAC
CGGCCCAAGCTGGGCGTCCACGAGGGCTCGGGCACCACGTCCTCGTTCTCCCGGCTGCTG
CTGGACCACGGTGTCGCCGAGGACCGCGTCCACGAGGCGAAGCGGCAGGTGGTGCGCGAG
CTGTTCGATCTCACGGTCGGGGGCGGACGGCACCCCTCCGAGGTGGACACCGACGATGTG
GTGCGCTCCGTGGCCGACCGGACCGCGCGGGGGGCGGCCTAG

# Drug_Target_3_General_Function:
Amino acid transport and metabolism

# Drug_Target_3_General_References:
10681345	Jensen SE, Elder KJ, Aidoo KA, Paradkar AS: Enzymes catalyzing the early steps of clavulanic acid biosynthesis are encoded by two sets of paralogous genes in Streptomyces clavuligerus. Antimicrob Agents Chemother. 2000 Mar;44(3):720-6.
9689037	Bachmann BO, Li R, Townsend CA: beta-Lactam synthetase: a new biosynthetic enzyme. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9082-6.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2885

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
54530

# Drug_Target_3_Name:
Carboxyethyl-arginine beta-lactam-synthase

# Drug_Target_3_Number_of_Residues:
513

# Drug_Target_3_PDB_ID:
1MC1

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00733	Asn_synthase

# Drug_Target_3_Protein_Sequence:
>Carboxyethyl-arginine beta-lactam-synthase
MGAPVLPAAFGFLASARTGGGRAPGPVFATRGSHTDIDTPQGERSLAATLVHAPSVAPDR
AVARSLTGAPTTAVLAGEIYNRDELLSVLPAGPAPEGDAELVLRLLERYDLHAFRLVNGR
FATVVRTGDRVLLATDHAGSVPLYTCVAPGEVRASTEAKALAAHRDPKGFPLADARRVAG
LTGVYQVPAGAVMDIDLGSGTAVTHRTWTPGLSRRILPEGEAVAAVRAALEKAVAQRVTP
GDTPLVVLSGGIDSSGVAACAHRAAGELDTVSMGTDTSNEFREARAVVDHLRTRHREITI
PTTELLAQLPYAVWASESVDPDIIEYLLPLTALYRALDGPERRILTGYGADIPLGGMHRE
DRLPALDTVLAHDMATFDGLNEMSPVLSTLAGHWTTHPYWDREVLDLLVSLEAGLKRRHG
RDKWVLRAAMADALPAETVNRPKLGVHEGSGTTSSFSRLLLDHGVAEDRVHEAKRQVVRE
LFDLTVGGGRHPSEVDTDDVVRSVADRTARGAA

# Drug_Target_3_Reaction:
ATP + L-N2-(2-carboxyethyl)arginine = AMP + diphosphate + deoxyamidinoproclavaminate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
ATP + L-2-N-(2-carboxyethyl)arginine = AMP + diphosphate + deoxyamidinoproclavaminate

# Drug_Target_3_SwissProt_ID:
Q9R8E3

# Drug_Target_3_SwissProt_Name:
BLS_STRCL

# Drug_Target_3_Synonyms:
Beta-lactam synthetase
EC 6.3.3.4

# Drug_Target_3_Theoretical_pI:
6.33

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
M15811

# Drug_Target_4_GenBank_ID_Protein:
143279

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
nadE

# Drug_Target_4_Gene_Sequence:
>819 bp
ATGAGCATGCAGGAAAAGATTATGCGTGAGTTACATGTGAAGCCCTCAATTGATCCAAAG
CAAGAAATTGAGGACCGAGTCAATTTTTTAAAACAATATGTAAAGAAAACCGGTGCTAAA
GGCTTTGTATTGGGAATCAGCGGGGGCCAGGATTCAACACTTGCGGGAAGACTCGCTCAG
CTTGCGGTGGAGAGCATTCGCGAGGAGGGCGGAGACGCTCAATTTATCGCGGTCCGTCTT
CCGCATGGCACACAGCAGGATGAAGACGATGCCCAGCTTGCTTTGAAGTTTATTAAGCCG
GATAAATCATGGAAGTTTGATATTAAATCGACAGTCAGCGCTTTTTCTGATCAGTATCAG
CAGGAAACAGGCGATCAGCTGACGGACTTTAATAAAGGAAACGTAAAAGCAAGAACAAGA
ATGATCGCGCAATACGCGATCGGCGGCCAGGAAGGTCTTCTTGTGTTAGGAACAGACCAT
GCTGCTGAAGCAGTGACTGGTTTCTTTACGAAGTACGGTGACGGCGGAGCAGACCTCCTG
CCGCTGACAGGCTTGACGAAGCGCCAGGGAAGAACCTTGCTGAAAGAGCTGGGTGCACCG
GAACGCTTATACTTAAAAGAACCGACTGCCGATCTGCTCGACGAAAAACCGCAGCAGTCG
GATGAAACAGAGCTTGGCATTTCCTACGACGAGATTGACGATTATCTCGAAGGAAAAGAA
GTATCAGCGAAAGTATCAGAAGCGCTGGAAAAACGCTACAGCATGACTGAACATAAACGC
CAGGTTCCGGCGTCTATGTTTGATGACTGGTGGAAATAA

# Drug_Target_4_General_Function:
Coenzyme transport and metabolism

# Drug_Target_4_General_References:
11375500	Devedjiev Y, Symersky J, Singh R, Jedrzejas M, Brouillette C, Brouillette W, Muccio D, Chattopadhyay D, DeLucas L: Stabilization of active-site loops in NH3-dependent NAD+ synthetase from Bacillus subtilis. Acta Crystallogr D Biol Crystallogr. 2001 Jun;57(Pt 6):806-12. Epub 2001 May 25.
12077433	Symersky J, Devedjiev Y, Moore K, Brouillette C, DeLucas L: NH3-dependent NAD+ synthetase from Bacillus subtilis at 1 A resolution. Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1138-46. Epub 2002 Jun 20.
1556067	Mitchell C, Morris PW, Vary JC: Identification of proteins phosphorylated by ATP during sporulation of Bacillus subtilis. J Bacteriol. 1992 Apr;174(8):2474-7.
2118513	Albertini AM, Galizzi A: The Bacillus subtilis outB gene is highly homologous to an Escherichia coli ntr-like gene. J Bacteriol. 1990 Sep;172(9):5482-5.
2435704	Albertini AM, Caramori T, Henner D, Ferrari E, Galizzi A: Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J Bacteriol. 1987 Apr;169(4):1480-4.
7890752	Nessi C, Albertini AM, Speranza ML, Galizzi A: The outB gene of Bacillus subtilis codes for NAD synthetase. J Biol Chem. 1995 Mar 17;270(11):6181-5.
8895556	Rizzi M, Nessi C, Mattevi A, Coda A, Bolognesi M, Galizzi A: Crystal structure of NH3-dependent NAD+ synthetase from Bacillus subtilis. EMBO J. 1996 Oct 1;15(19):5125-34.
8969502	Yamane K, Kumano M, Kurita K: The 25 degrees-36 degrees region of the Bacillus subtilis chromosome: determination of the sequence of a 146 kb segment and identification of 113 genes. Microbiology. 1996 Nov;142 ( Pt 11):3047-56.
9298659	Antelmann H, Bernhardt J, Schmid R, Mach H, Volker U, Hecker M: First steps from a two-dimensional protein index towards a response-regulation map for Bacillus subtilis. Electrophoresis. 1997 Aug;18(8):1451-63.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9753692	Rizzi M, Bolognesi M, Coda A: A novel deamido-NAD+-binding site revealed by the trapped NAD-adenylate intermediate in the NAD+ synthetase structure. Structure. 1998 Sep 15;6(9):1129-40.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2910

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
30396

# Drug_Target_4_Name:
NH(3)-dependent NAD(+) synthetase

# Drug_Target_4_Number_of_Residues:
272

# Drug_Target_4_PDB_ID:
1IH8

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF02540	NAD_synthase

# Drug_Target_4_Protein_Sequence:
>NH(3)-dependent NAD(+) synthetase
MSMQEKIMRELHVKPSIDPKQEIEDRVNFLKQYVKKTGAKGFVLGISGGQDSTLAGRLAQ
LAVESIREEGGDAQFIAVRLPHGTQQDEDDAQLALKFIKPDKSWKFDIKSTVSAFSDQYQ
QETGDQLTDFNKGNVKARTRMIAQYAIGGQEGLLVLGTDHAAEAVTGFFTKYGDGGADLL
PLTGLTKRQGRTLLKELGAPERLYLKEPTADLLDEKPQQSDETELGISYDEIDDYLEGKE
VSAKVSEALEKRYSMTEHKRQVPASMFDDWWK

# Drug_Target_4_Reaction:
ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Catalyzes a key step in NAD biosynthesis, transforming deamido-NAD into NAD by a two-step reaction

# Drug_Target_4_SwissProt_ID:
P08164

# Drug_Target_4_SwissProt_Name:
NADE_BACSU

# Drug_Target_4_Synonyms:
EC 6.3.1.5
GSP38
General stress protein 38
Spore outgrowth factor B
Sporulation protein outB

# Drug_Target_4_Theoretical_pI:
4.83

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Nucleus (Probable)

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
NMNAT3

# Drug_Target_5_GenBank_ID_Gene:
AF345564

# Drug_Target_5_GenBank_ID_Protein:
14029540

# Drug_Target_5_GeneCard_ID:
NMNAT3

# Drug_Target_5_Gene_Name:
NMNAT3

# Drug_Target_5_Gene_Sequence:
>759 bp
ATGAAGAGCCGAATACCTGTGGTGCTCCTGGCCTGTGGCTCCTTTAACCCCATCACCAAC
ATGCACCTGCGCATGTTTGAGGTGGCCAGAGATCACCTACACCAAACAGGAATGTACCAG
GTCATCCAGGGTATCATCTCTCCTGTCAACGACACCTATGGGAAGAAAGACCTCGCAGCT
TCTCATCACCGAGTGGCCATGGCCCGGCTGGCCCTGCAGACATCCGACTGGATCCGGGTG
GACCCTTGGGAGAGTGAGCAGGCACAGTGGATGGAGACAGTGAAGGTGCTGAGGCATCAT
CACAGCAAACTGCTCAGATCTCCACCCCAGATGGAAGGCCCAGACCATGGCAAGGCACTC
TTCTCGACCCCTGCAGCTGTGCCTGAGCTGAAGCTTCTCTGTGGGGCAGACGTCTTGAAG
ACCTTCCAGACCCCCAACCTCTGGAAGGATGCGCACATCCAGGAAATAGTGGAGAAGTTT
GGCTTGGTGTGCGTGGGCCGAGTAAGTCACGACCCAAAAGGTTACATCGCAGAATCTCCC
ATCCTACGGATGCACCAGCACAACATTCACCTGGCCAAGGAGCCTGTGCAGAATGAGATC
AGTGCCACATACATCAGGCGAGCCTTGGGCCAAGGGCAGAGCGTAAAGTACCTGATTCCC
GATGCTGTCATCACGTACATCAAGGACCATGGCCTCTACACCAAGGGCAGTACCTGGAAA
GGCAAAAGCACCCAGAGCACTGAGGGCAAGACAAGCTAG

# Drug_Target_5_General_Function:
Coenzyme transport and metabolism

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
HGNC:20989

# Drug_Target_5_HPRD_ID:
16370

# Drug_Target_5_ID:
3333

# Drug_Target_5_Locus:
3q23

# Drug_Target_5_Molecular_Weight:
28322

# Drug_Target_5_Name:
Nicotinamide mononucleotide adenylyltransferase 3

# Drug_Target_5_Number_of_Residues:
252

# Drug_Target_5_PDB_ID:
1NUU

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_5_Protein_Sequence:
>Nicotinamide mononucleotide adenylyltransferase 3
MKSRIPVVLLACGSFNPITNMHLRMFEVARDHLHQTGMYQVIQGIISPVNDTYGKKDLAA
SHHRVAMARLALQTSDWIRVDPWESEQAQWMETVKVLRHHHSKLLRSPPQMEGPDHGKAL
FSTPAAVPELKLLCGADVLKTFQTPNLWKDAHIQEIVEKFGLVCVGRVGHDPKGYIAESP
ILRMHQHNIHLAKEPVQNEISATYIRRALGQGQSVKYLIPDAVITYIKDHGLYTKGSTWK
GKSTQSTEGKTS

# Drug_Target_5_Reaction:
ATP + nicotinamide ribonucleotide = diphosphate + NAD+

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
ATP + nicotinamide ribonucleotide = diphosphate + NAD(+)

# Drug_Target_5_SwissProt_ID:
Q96T66

# Drug_Target_5_SwissProt_Name:
NMNA3_HUMAN

# Drug_Target_5_Synonyms:
EC 2.7.7.1
NMN adenylyltransferase 3

# Drug_Target_5_Theoretical_pI:
9.69

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasmic

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
D49692

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
cyaC

# Drug_Target_6_Gene_Sequence:
>3609 bp
ATGAGTTCCCCCAACAGAAAATTGAAGCCCACCATATTAGTGGTTGATGATGAGCCAGAT
AATTTAGATCTGCTATACCGGACTTTCCATCGGGAATTTAAAGTTCTCAAAGCCGAAAGT
GGGCCGGCTGCATTGAAGATCTTAGAAGAGGTGGGGGAAGTAGCAGTAATTATCTCTGAT
CAGCGGATGCCCTATATGAGTGGCACAGAGTTTCTCAGTTTGACCGCGACTCAATATCCC
GATTCGATCCGCATTATCCTCACTGGTTATACGGATGTTGAAGACCTGGTAGAGGCAATT
AACTCCGGTAAGGTGTTTAAATATGTCACTAAACCTTGGAAATCTGATGAACTCAAGGCG
ATCGTTCAGCAAGGTTTAGAAACTCATAATGTCCTGAAATCTCGCACAGAGGAACTACGC
CTAGCACAAAAACAGGAATCGTTACTTTATGAAGTGACAAGTACCATTCGCGCCTGTCCT
AATTCCCAGGAAATGTTGCAGCGCATAGTTGAAACAGTGGGTAAAATGTTTGAGGTGAGC
TATTGTCTGCTGCGTTCATTCGGTGTGGGTTCAGACCTGATAGGGCTGGGGGCTGGAGTC
AGCCCTACCAAACAGGATATCACTGCTACACAAGGGAAGGAGTGGTTCGCATACTTAGCG
GAAGGTCAGAATCATCAAAATTCCACGACAGACAACATCAGCGTTATCAATAATAATGAT
CTGGAATTGAGATCCCTGGTTTGGGAAACTACGGAAGTAATGATTCTTTCGGAAGGTTTG
GGAAATGATATTTCTGACCACGATGGACCAGAATGGCAGCAGCGACGAGACGTTTACCAA
CGTGCAGATATTCGCTCCAGTTTGATAGTGCCTCTGTATTACCGTCAGGAATTGTTGGCG
GTTTTGGCGCTGCACCACACGGGATCGCCCCGTAATTGGCATGAACATGAAGTGCAGTTA
GCTGCGGGTGTAGCAGATCAGGCGGCTTTGGCATTGTCTCAGGTGCGCGCATACGAGCAG
GTGCGAGAATTGGCTCGTAGGGAAGCGCTGGTTAATACGATTACCAATGCTATTCGGTCT
AGTCTTGACCCTCAGAAAATTTTTGCGGCTATCACTGAGCAATTGGGGGAGGCTTTGGAG
GTTGATGGCTGTGCTTTGTCTCTCTGGAGTCCGGGAGATGAATATATGCAGTGTGTAGGC
CTTTATAATGCGGCGATTAAAGAAACAGTAGTAGAGACTAGACCGGCGGCTTTGTCTGAA
CCTGATACCAGCACGACGACGAATTTGCCCCTATTGGGGGTAGAAACTAATCAATCCATT
GAGTCCGATCAGTCCGATGATTTGCCTCAGTCGGCGGCTCCTATTAGTGGCAACCCGGTG
CTTCAGGAATTGATTAGAACTCGCGCTCCGGTGGCGATCGCTGATATCGAACAGCGACCA
GACTCGATGGTGATGTTGCCTTTGCGATCGCCTTCTAAGGCTCTATTGGTTGTGCCACTA
TTGCTCGATGGTGATATTATTGGCAGCATATCCCTACGCCAAAATCACCAAGTTCGCCAT
TGGCAACCCTCCGAAATTGATATGGTCCTGTTGGTGGCAGCCCAAGCCGCTTTGGCGGTA
CAGCAGGCTCGTCTATACCAAAAAACACGCCAGCAAGCAGAACGCCTATTAGAAGCCGAC
CGCCTCAAAACTGAGTTTTTTCAAAATGTCTCCCACGAGTTTCGCACCCCTTTGACTTTG
ATGATAGGTCCTTTGGAAACGGTGGTTAATCAACAGCAGGATCTGTCATTAGACCAAGCG
AAAATTGCTCTGCGTAACTCCAGGCGACTATTGCGCTTGGTTAATCAATTATTGGATTTG
CAACGGTTTGATGCGGGACGAATGCAGCCCAGTTTTCGCCCCTGTGACCTGGTGGAGTTT
TGTCAGCAAACGGTGGAATCATTTAAGTCTTATTGCGATCGCAAACAAATTAATCTAGTT
ACCAATTTACAGAGTTGCCCCCAACTTTATCTTGATCTGGAAAGGTTTGATAAAGTCCTT
TACAATTTGCTCTCTAATGCCATGAAGTTTACCCCCACCGATGGCACTATTACCGTTAGT
CTCCAGCCCGAAGGGAATTATTGCCGTCTTATGGTCAAAGATACCGGGATTGGTATTAAA
CAAGAACAACTCCCCCATTTATTTGAACGCTTCCGACAAGCTGAAGGTTCAGCCAATCGC
TCCTTTGAGGGGAGTGGCTTGGGATTGGCTCTGGTTAAAGAGTTGGTCGAACTCCATCAT
GGTCGCATTACTGTAGAGTCTGAGTATGGTCAGGGAACTACATTTACCGTCTGGCTACAA
ATGGGGAATCTTCATCTACCACCCTCGCCTCTCCTTGATGTTCCCGCTGAGTTTGATGCA
CGTCGAGCAGCCGTAGAATTGGCTGATGTGGAGGTCGATTTACCAGATGTACAAATTGAC
GACATAAATCTGCCGGAGGTTTTGGTTGCTGACGGTTCGGCTTCCCTCACGGACCACGGA
CAGTTGGGGTCTAATACTGTCCTGGTGGTGGATGATAACCCCGATTTGCGCCGCTATGTG
TCGATGATGTTGCAAAATGCCGGATTTAATGCGGTTTTGGCTAAGAATGGCGCTGATGGT
TTTAACAAGGCTCAGACTTATCATCCTGATGTGATTGTTACTGATTTGATGATGCCCCAG
GTGTCTGGGTTGGAGTTGATTCGCATGATTCGCTCCTCACCTGAACTTAGGGGAACTCCA
ATTATTTTGTTGACTGCTAAGGCTGATGAGGATACCCGCATCGAAGGGGTTGAGCGCGGC
GCTGATGCCTATGTTTCTAAGCCTTTTAATGACCGGGAGTTGATAGCTGAGGTCAGGAAT
TTACAGGCCCTCAAGGCAGAGGAACGACGGGTAGCCCATTTGAATAAGTATCTGACTGAA
TCAGTATTGCGACGGTTTTTGCCGGAGTCTATGGTCAAAAAGGCGGCGGCGGGGGACTTG
ACTCTGGATTTGCGCCCGGAACCGAGGCTGATTACCATTTTATTTAGTGATATTGTCGGT
TTTACTCGGATGTCTAATGCTCTACAGTCTCAGGGGGTGGCGGAATTGCTTAATGAGTAT
TTGGGAGAAATGACTCGGGCGGTTTTTGAGAATCAGGGGACTGTTGACAAGTTTGTAGGA
GATGCGATTATGGCTTTGTATGGAGCCCCGGAGGAGATGAGCCCCTCTGAACAAGTCCGA
CGCGCGATCGCTACGGCTAGACAAATGTTGGTGGCTCTCGAAAAACTTAACCAGGGTTGG
CAGGAACGAGGTTTGGTGGGCCGTAATGAGGTTCCTCCGGTGCGGTTCCGCTGTGGGATT
CACCAGGGTATGGCTGTGGTGGGGTTGTTTGGTTCCCAAGAGCGATCGGATTTTACGGCG
ATCGGTCCTTCGGTTAATATTGCTGCCCGTCTTCAGGAGGCTACTGCCCCCAACAGCATT
ATGGTATCCGCTATGGTGGCTCAGTATGTCCCCGATGAGGAGATTATTAAGCGCGAATTT
CTCGAACTTAAAGGCATTGATGAGCCGGTAATGACTTGTGTGATTAACCCAAATATGCTG
AATCAGTAA

# Drug_Target_6_General_Function:
Involved in phosphorus-oxygen lyase activity

# Drug_Target_6_General_References:
9297847	Kasahara M, Yashiro K, Sakamoto T, Ohmori M: The Spirulina platensis adenylate cyclase gene, cyaC, encodes a novel signal transduction protein. Plant Cell Physiol. 1997 Jul;38(7):828-36.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
4655

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
133925

# Drug_Target_6_Name:
Adenylate cyclase

# Drug_Target_6_Number_of_Residues:
1202

# Drug_Target_6_PDB_ID:
1WC6

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00072	Response_reg
PF00211	Guanylate_cyc
PF00512	HisKA
PF01590	GAF
PF02518	HATPase_c

# Drug_Target_6_Protein_Sequence:
>Adenylate cyclase
MSSPNRKLKPTILVVDDEPDNLDLLYRTFHREFKVLKAESGPAALKILEEVGEVAVIISD
QRMPYMSGTEFLSLTATQYPDSIRIILTGYTDVEDLVEAINSGKVFKYVTKPWKSDELKA
IVQQGLETHNVLKSRTEELRLAQKQESLLYEVTSTIRACPNSQEMLQRIVETVGKMFEVS
YCLLRSFGVGSDLIGLGAGVSPTKQDITATQGKEWFAYLAEGQNHQNSTTDNISVINNND
LELRSLVWETTEVMILSEGLGNDISDHDGPEWQQRRDVYQRADIRSSLIVPLYYRQELLA
VLALHHTGSPRNWHEHEVQLAAGVADQAALALSQVRAYEQVRELARREALVNTITNAIRS
SLDPQKIFAAITEQLGEALEVDGCALSLWSPGDEYMQCVGLYNAAIKETVVETRPAALSE
PDTSTTTNLPLLGVETNQSIESDQSDDLPQSAAPISGNPVLQELIRTRAPVAIADIEQRP
DSMVMLPLRSPSKALLVVPLLLDGDIIGSISLRQNHQVRHWQPSEIDMVLLVAAQAALAV
QQARLYQKTRQQAERLLEADRLKTEFFQNVSHEFRTPLTLMIGPLETVVNQQQDLSLDQA
KIALRNSRRLLRLVNQLLDLQRFDAGRMQPSFRPCDLVEFCQQTVESFKSYCDRKQINLV
TNLQSCPQLYLDLERFDKVLYNLLSNAMKFTPTDGTITVSLQPEGNYCRLMVKDTGIGIK
QEQLPHLFERFRQAEGSANRSFEGSGLGLALVKELVELHHGRITVESEYGQGTTFTVWLQ
MGNLHLPPSPLLDVPAEFDARRAAVELADVEVDLPDVQIDDINLPEVLVADGSASLTDHG
QLGSNTVLVVDDNPDLRRYVSMMLQNAGFNAVLAKNGADGFNKAQTYHPDVIVTDLMMPQ
VSGLELIRMIRSSPELRGTPIILLTAKADEDTRIEGVERGADAYVSKPFNDRELIAEVRN
LQALKAEERRVAHLNKYLTESVLRRFLPESMVKKAAAGDLTLDLRPEPRLITILFSDIVG
FTRMSNALQSQGVAELLNEYLGEMTRAVFENQGTVDKFVGDAIMALYGAPEEMSPSEQVR
RAIATARQMLVALEKLNQGWQERGLVGRNEVPPVRFRCGIHQGMAVVGLFGSQERSDFTA
IGPSVNIAARLQEATAPNSIMVSAMVAQYVPDEEIIKREFLELKGIDEPVMTCVINPNML
NQ

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
O32393

# Drug_Target_6_SwissProt_Name:
O32393_SPIPL

# Drug_Target_6_Synonyms:
EC 4.6.1.1

# Drug_Target_6_Theoretical_pI:
4.74

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AF408636

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
Not Available

# Drug_Target_7_Gene_Sequence:
>996 bp
ATGATCCATCTGTACGACGCAAAGTCGTTCGCTAAATTGCGCGCGGCCCAGTATGCAGCG
TTTCACACTGACGCTCCTGGTTCCTGGTTCGACCACACATCCGGGGTGCTCGAGTCGGTT
GAGGACGGCACGCCTGTTCTCGCCATCGGTGTCGAAAGCGGCGACGCCATCGTATTCGAC
AAGAATGCGCAGCGCATCGTCGCGTACAAGGAGAAATCCGTCAAAGCTGAGGATGGTTCC
GTCTCGGTCGTTCAAGTTGAGAACGGTTTCATGAAACAGGGCCATCGTGGATGGCTCGTC
GACCTCACTGGCGAGCTCGTCGGTTGCAGTCCGGTAGTCGCCGAGTTCGGTGGTCATCGT
TATGCGTCTGGCATGGTGATCGTCACTGGCAAGGGCAACTCCGGGAAGACTCCTCTCGTG
CACGCGTTGGGTGAGGCTCTCGGTGGTAAGGACAAATACGCTACCGTGCGGTTTGGCGAA
CCACTGTCGGGCTACAACACCGATTTCAACGTGTTCGTGGATGATATCGCTCGTGCAATG
CTCCAGCATCGTGTGATCGTGATTGACTCGCTGAAGAACGTCATCGGTGCAGCTGGTGGT
AATACCACTTCCGGTGGTATTTCTCGTGGCGCCTTCGACCTTCTTTCCGATATCGGCGCC
ATGGCTGCATCCCGTGGATGCGTAGTCATAGCGTCGCTCAACCCAACTTCGAATGACGAC
AAGATCGTCGAATTGGTCAAGGAAGCGAGCCGCTCCAACAGCACGTCTCTCGTTATCTCG
ACAGATGTCGACGGCGAATGGCAAGTACTGACACGTACCGGTGAAGGTCTGCAACGCCTG
ACACACACTCTGCAGACGAGTTATGGCGAGCATTCGGTCCTCACCATCCACACGAGTAAG
CAATCTGGTGGCAAACAAGCCTCCGGCAAAGCTATTCAGACCGTAATCAAAAACGACGAA
CTGGAATCGGTCCTTCGTCGTCTCACCTCCAACTGA

# Drug_Target_7_General_Function:
Not Available

# Drug_Target_7_General_References:
12033785	Gottlieb P, Potgieter C, Wei H, Toporovsky I: Characterization of phi12, a bacteriophage related to phi6: nucleotide sequence of the large double-stranded RNA. Virology. 2002 Apr 10;295(2):266-71.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
4774

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
35109

# Drug_Target_7_Name:
NTPase P4

# Drug_Target_7_Number_of_Residues:
331

# Drug_Target_7_PDB_ID:
1W4C

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
Not Available

# Drug_Target_7_Protein_Sequence:
>NTPase P4
MIHLYDAKSFAKLRAAQYAAFHTDAPGSWFDHTSGVLESVEDGTPVLAIGVESGDAIVFD
KNAQRIVAYKEKSVKAEDGSVSVVQVENGFMKQGHRGWLVDLTGELVGCSPVVAEFGGHR
YASGMVIVTGKGNSGKTPLVHALGEALGGKDKYATVRFGEPLSGYNTDFNVFVDDIARAM
LQHRVIVIDSLKNVIGAAGGNTTSGGISRGAFDLLSDIGAMAASRGCVVIASLNPTSNDD
KIVELVKEASRSNSTSLVISTDVDGEWQVLTRTGEGLQRLTHTLQTSYGEHSVLTIHTSK
QSGGKQASGKAIQTVIKNDELESVLRRLTSN

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not Available

# Drug_Target_7_SwissProt_ID:
Q94M05

# Drug_Target_7_SwissProt_Name:
Q94M05_9VIRU

# Drug_Target_7_Synonyms:
Not Available

# Drug_Target_7_Theoretical_pI:
6.51

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasmic

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
BX842578

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
lipJ

# Drug_Target_8_Gene_Sequence:
>1389 bp
TTAGCGCGTGCGGGTGGCGTCGTCGCGCATGAGCACGCATAGCCGCCATCTGCCCGGTAC
GCCCTTGAGTTCCTGCTCACCACGCTCGGCGAACCGGTGCCGTGATCCGGCGACGATGTC
TCGCACGGTCGAGGACACCAGCACCTCACTGGGTCCGGCCAGCGCGCAGACGCGCGCACC
GATATGCACGGCCACGCCGGCGACGTCGGTACCGTGCGAGGCATCGCGCACCTCGACCTC
GCCCGCATGAATACCGATCCGGACCTCAATACCCAGCGCGGCGACCGCGTCGACGATGTC
GTCCGCGCACGCGATCGCGGCACTCGGACTGGTGAACGTCGCGACGAAACCGTCACCGGC
CGTGTTCACTTCGCGACCGCCGAACCGCTGGATTTCGTGGCACACGATGGTGTCGTGGTT
GTCCAACAGGTCGCGCCATCGGTCGTCGCCGAGCGCGGCGGCGTGCTGGGTCGAGCCGAC
GATGTCGGTAAACATGATGGTGGCAAGCATGCGCTCGGCGTCAGCGCCGCCGCGCACGCC
GGTGATGAATTCCTCGATTTCATCGAGCATCGGCCCGGTGTCGCCAACCCAGTACAGGGT
ATCGGTGCCGGGTAGTTCGACCAAGCGGGATCCAGCGATGTGCTCGGCGAGGTAGCGACC
ATGTCCCACCGGGATGTACGTCGATCCGACACGGTGCAAGATCAGTGTTGGAGCCTCGAT
GTGTCCCAAGACATCTCGTACGTCGGCCTCGGCTATGACCTTTGAAACGGCACGGGCAAT
GCTCGGCGGTCCGGCACGGTTGCCGGCGAGATCCCACCAGGCTCGAAACACGTCATCTCC
GGCCACGGTAGGAGCCACGATGCTCAGCACGTCGAAGCCCCGCTCGACGGCATCCGGTTC
CAGCGCCACCGTCAGGAACGGGTCAGCTCGACGAACCTGGGCGCCTACCGGGTAGTCGGG
CGCCCATAGTGGGCGCGCCGAGCCGTTGACGACGATCAGGCTGCGCACCCGCTCGGGGTA
GTCGGCGGCGAGAACAAGTCCGTTCATGGCGTGGAAACTGGGCGCGAAAATTGTCGCCTG
CTCGCATCCGACCGCGTCCATCACCGCGATCGCGTCCTGGGCCCAGAACTTCGGCCCCAG
CGTGGTTATCGCGGCGAGCCGTGACGACAGGCCGACCCCACGATGGTCGAGGCGGATCAC
CCTGCTGAATGACGCAAGACGGCGATGGAAACGGTACAGCGATGGCTCGTCGTCGATCGA
GTCGATCGGCACGAACGGCCCCGGCAACACCAGCAGATCCGTCGGACCGTCACCCAGCAC
CTGGTAGGCGATATCCATGTCGCCGCATTTTGCGTAGCGGGTCCTGTGAATGTGGGGAGC
CTGCGCCAC

# Drug_Target_8_General_Function:
Involved in phosphorus-oxygen lyase activity

# Drug_Target_8_General_References:
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
4775

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
49717

# Drug_Target_8_Name:
PROBABLE LIGNIN PEROXIDASE LIPJ

# Drug_Target_8_Number_of_Residues:
462

# Drug_Target_8_PDB_ID:
1YBU

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00561	Abhydrolase_1

# Drug_Target_8_Protein_Sequence:
>PROBABLE LIGNIN PEROXIDASE LIPJ
MAQAPHIHRTRYAKCGDMDIAYQVLGDGPTDLLVLPGPFVPIDSIDDEPSLYRFHRRLAS
FSRVIRLDHRGVGLSSRLAAITTLGPKFWAQDAIAVMDAVGCEQATIFAPSFHAMNGLVL
AADYPERVRSLIVVNGSARPLWAPDYPVGAQVRRADPFLTVALEPDAVERGFDVLSIVAP
TVAGDDVFRAWWDLAGNRAGPPSIARAVSKVIAEADVRDVLGHIEAPTLILHRVGSTYIP
VGHGRYLAEHIAGSRLVELPGTDTLYWVGDTGPMLDEIEEFITGVRGGADAERMLATIMF
TDIVGSTQHAAALGDDRWRDLLDNHDTIVCHEIQRFGGREVNTAGDGFVATFTSPSAAIA
CADDIVDAVAALGIEVRIGIHAGEVEVRDASHGTDVAGVAVHIGARVCALAGPSEVLVSS
TVRDIVAGSRHRFAERGEQELKGVPGRWRLCVLMRDDATRTR

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
O07732

# Drug_Target_8_SwissProt_Name:
O07732_MYCTU

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
5.41

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
U17224

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
carA

# Drug_Target_9_Gene_Sequence:
>1512 bp
GTGAGCAATAGTTTTTGCGTTGTTTATAAAGGTTCTGATACCGATATAAATAATATCCAA
CGCGACTTCGACGGAAAGGGCGAAGCATTATCTAATGGCTATCTTTTTATCGAACAGAAT
GGCCATTATCAGAAGTGTGAGATGGAAAGAGGAACGGCCTACCTGATAGGCTCGCTGTAC
AATCGGACGTTTCTGATCGGATTGGCCGGTGTGTGGGAAGGCGAGGCTTATCTGGCAAAT
GATGCCGAGCTGTTAGCGTTGCTGTTCACGCGTTTGGGAGCGAATGCACTGGCGCTGGCT
GAAGGTGACTTCTGCTTTTTCATTGATGAACCAAACGGCGAATTGACGGTGATTACCGAG
TCGCGTGGTTTCTCGCCGGTTCATGTCGTACAGGGCAAAAAAGCCTGGATGACCAATAGC
CTTAAACTGGTTACTGCGGCAGAAGGTGAAGGCGCGCTGTGGTTTGAAGAAGAGGCGTTG
GTGTGCCAGTCGCTGATGCGAGCGGATACCTATACGCCGGTGAAAAATGCGCAGCGTCTT
AAGCCGGGAGCGGTGCATGTTCTTACGCACGATAGCGAAGGTTATTCTTTCGTTGAAAGC
CGCACGCTGACCACACCAGCCAGCAACCAATTGTTAGCGCTCCCGCGTGAACCGCTGCTG
GCATTGATTGATCGCTACCTTAATGCTCCGCTTGAGGATTTAGCGCCGCGCTTTGATACC
GTAGGAATTCCCTTGTCAGGCGGTCTGGATTCCAGCCTGGTAACGGCGCTCGCCAGTCGT
CATTTCAAAAAATTGAATACGTATTCGATTGGTACGGAACTCAGCAATGAGTTTGAGTTT
TCTCAACAGGTTGCTGATGCACTCGGTACACATCATCAGATGAAAATTCTGTCCGAAACT
GAAGTGATCAACGGCATCATCGAATCCATCTATTACAACGAAATATTTGACGGCTTATCC
GCTGAAATCCAATCCGGGTTGTTCAATGTCTATCGTCAGGCTCAGGGGCAGGTGTCTTGC
ATGCTCACCGGATATGGTTCCGACCTGCTCTTTGGCGGCATACTGAAACCAGGAGCGCAG
TATGACAATCCGAATCAGCTGCTTGCCGAGCAAGTGTACCGGACGCGTTGGACAGGGGAG
TTTGCTACCCACGGTGCTTCCTGTTACGGCATTGATATTCGCCACCCCTTCTGGAGCCAT
TCCCTAATCTCTCTATGTCATGCGCTACATCCTGATTACAAAATTTTCGACAACGAAGTC
AAAAACATCCTGCGTGAATACGCCGATTCGCTGCAATTGCTGCCGAAAGACATTGTCTGG
CGCAAGAAAATCGGCATTCACGAAGGTTCCTCCGTCAATCAGGCCTTTGCGAATGTTCTC
GGGTCAACGGTTGATAACTACCAGACCAAAAGTCGCTTTACCTACCGTGTTTATCAAGCC
TTCCTTCGTGGCCGTCTCTCCATTACAGATGTGACGCCCTCTCAGCTTAAAGATCTGATT
AAAAAGGATTAA

# Drug_Target_9_General_Function:
Involved in asparagine synthase (glutamine-hydrolyzing) activity

# Drug_Target_9_General_References:
9402024	McGowan SJ, Sebaihia M, O'Leary S, Hardie KR, Williams P, Stewart GS, Bycroft BW, Salmond GP: Analysis of the carbapenem gene cluster of Erwinia carotovora: definition of the antibiotic biosynthetic genes and evidence for a novel beta-lactam resistance mechanism. Mol Microbiol. 1997 Nov;26(3):545-56.
9614345	McGowan SJ, Bycroft BW, Salmond GP: Bacterial production of carbapenems and clavams: evolution of beta-lactam antibiotic pathways. Trends Microbiol. 1998 May;6(5):203-8.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
4776

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
55999

# Drug_Target_9_Name:
CarA

# Drug_Target_9_Number_of_Residues:
503

# Drug_Target_9_PDB_ID:
1Q19

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00733	Asn_synthase

# Drug_Target_9_Protein_Sequence:
>CarA
MSNSFCVVYKGSDTDINNIQRDFDGKGEALSNGYLFIEQNGHYQKCEMERGTAYLIGSLY
NRTFLIGLAGVWEGEAYLANDAELLALLFTRLGANALALAEGDFCFFIDEPNGELTVITE
SRGFSPVHVVQGKKAWMTNSLKLVTAAEGEGALWFEEEALVCQSLMRADTYTPVKNAQRL
KPGAVHVLTHDSEGYSFVESRTLTTPASNQLLALPREPLLALIDRYLNAPLEDLAPRFDT
VGIPLSGGLDSSLVTALASRHFKKLNTYSIGTELSNEFEFSQQVADALGTHHQMKILSET
EVINGIIESIYYNEIFDGLSAEIQSGLFNVYRQAQGQVSCMLTGYGSDLLFGGILKPGAQ
YDNPNQLLAEQVYRTRWTGEFATHGASCYGIDIRHPFWSHSLISLCHALHPDYKIFDNEV
KNILREYADSLQLLPKDIVWRKKIGIHEGSSVNQAFANVLGSTVDNYQTKSRFTYRVYQA
FLRGRLSITDVTPSQLKDLIKKD

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
Q9XB61

# Drug_Target_9_SwissProt_Name:
Q9XB61_ERWCA

# Drug_Target_9_Synonyms:
Not Available

# Drug_Target_9_Theoretical_pI:
5.21

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB02596
